News from qrxpharma limited A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

Jul 11, 2014, 09:00 ET QRxPharma Provides Feedback On End-of-Review Meeting With The FDA On Moxduo®

QRxPharma Limited (ASX: QRX and OTCQX: QRXPY) today provided feedback on its 9 July End-of-Review (EOR) meeting with the United States Food and Drug...


Jul 09, 2014, 09:02 ET QRxPharma Announces Board Resignations

QRxPharma Limited (ASX: QRX and OTCQX: QRXPY) announced today that Chairman, Dr. Peter Farrell and Director, Dr. Gary Pace have resigned from the...


May 27, 2014, 06:00 ET QRxPharma Receives Complete Response Letter From FDA Regarding Moxduo® NDA

QRxPharma Limited (ASX: QRX and OTCQX: QRXPY) announced today the United States Food and Drug Administration (FDA) has issued a Complete Response...


Mar 24, 2014, 08:00 ET FDA Sets 22 April 2014 For Moxduo® Advisory Committee Meeting

QRxPharma Limited (ASX: QRX and OTCQX: QRXPY) announced today the United States Food and Drug Administration (FDA) has set 22 April 2014 as the date...


Dec 13, 2013, 09:00 ET QRxPharma Completes A$11.6 Million Capital Raising

QRxPharma Limited (ASX: QRX and OTCQX: QRXPY) today announced the successful completion of its Share Purchase Plan (SPP) to existing shareholders...


Dec 11, 2013, 09:00 ET QRxPharma Announces 25 May 2014 as New PDUFA Date for MOXDUO® NDA

QRxPharma Limited (ASX: QRX and OTCQX: QRXPY) announced today that the United States Food and Drug Administration (FDA) has established 25 May 2014...


Nov 26, 2013, 09:00 ET QRxPharma Refiles MOXDUO® New Drug Application with the FDA

QRxPharma Limited (ASX: QRX and OTCQX: QRXPY) announced today that the Company resubmitted its MOXDUO® New Drug Application (NDA). At a meeting in...


Nov 13, 2013, 09:00 ET QRxPharma Announces Successful Completion Of A$7.5 Million Placement

QRxPharma Limited (ASX: QRX and OTCQX: QRXPY) ("QRxPharma") announced today the successful completion of a Placement to institutional and...


Oct 15, 2013, 09:00 ET QRxPharma Extends MOXDUO® License With Aspen

QRxPharma Limited (ASX: QRX and OTCQX: QRXPY) announced today the execution of a licensing agreement with Aspen Pharmacare Holdings Limited (JSE:...


Oct 09, 2013, 09:00 ET QRxPharma Reports Positive Meeting With The FDA On MOXDUO®

QRxPharma Limited (ASX: QRX and OTCQX: QRXPY) announced today the results of its meeting on October 3 with the United States Food and Drug...


Sep 11, 2013, 09:00 ET QRxPharma Announces MOXDUO® License With Aspen

QRxPharma Limited (ASX: QRX and OTCQX: QRXPY) announced today execution of a licensing agreement with Aspen Pharma Pty Ltd, one of the Australian...


Sep 06, 2013, 09:00 ET FDA Schedules Review Meeting With QRxPharma Regarding MOXDUO® NDA

QRxPharma Limited (ASX: QRX and OTCQX: QRXPY) announced today the United States Food and Drug Administration (FDA) has scheduled a meeting on 3...


Jul 22, 2013, 07:00 ET QRxPharma Announces Collaboration With Aesica

QRxPharma Limited (ASX: QRX and OTCQX: QRXPY) announced today execution of a Collaboration Agreement with Aesica Formulation Development Limited, a...


Jun 26, 2013, 09:14 ET QRxPharma Updates MOXDUO® NDA Review

QRxPharma Limited (ASX: QRX and OTCQX: QRXPY) announced today the planned 17 July 2013 US Food and Drug Administration (FDA) Advisory Committee...


Jun 12, 2013, 09:00 ET QRxPharma Granted US Patent On Hybrid Opioids

QRxPharma Limited (ASX: QRX and OTCQX: QRXPY) announced today that the United States Patent and Trademark Office (USPTO) issued the Company U.S....


May 17, 2013, 09:00 ET FDA Sets 17 July 2013 For MOXDUO® Advisory Committee Meeting

QRxPharma Limited (ASX: QRX and OTCQX: QRXPY) announced today the US Food and Drug Administration (FDA) has set 17 July 2013 as the date of the...


Mar 14, 2013, 09:00 ET FDA Sets 26 August 2013 As New PDUFA Date For MOXDUO® NDA

QRxPharma Limited (ASX: QRX and OTCQX: QRXPY) announced today the US Food and Drug Administration (FDA) has set 26 August 2013 as the Prescription...


Feb 28, 2013, 09:00 ET QRxPharma Resubmits MOXDUO® New Drug Application to the FDA

QRxPharma Limited (ASX: QRX and OTCQX: QRXPY) announced today that the Company resubmitted its MOXDUO® New Drug Application (NDA). As disclosed on 16 ...


Jan 16, 2013, 08:00 ET QRxPharma and FDA Establish Path Forward for Resubmission Of MOXDUO® New Drug Application

QRxPharma Limited (ASX: QRX and OTCQX: QRXPY) announced today that the steps necessary for approval of immediate release MOXDUO have been clarified...


May 23, 2012, 08:50 ET QRxPharma Granted Additional US Patent on MoxDuo®

QRxPharma Limited (ASX: QRX and OTCQX: QRXPY) announced today that the United States Patent and Trademark Office (USPTO) issued the Company U.S....


Mar 19, 2012, 08:50 ET QRxPharma Signs License and Option Agreement with Actavis

QRxPharma Limited (ASX: QRX and OTCQX: QRXPY) announced today execution of its License and Option Agreement (LOA) with Actavis, Inc. which finalised...


Nov 08, 2011, 08:45 ET QRxPharma Granted Target Date for FDA Action on MoxDuo® IR NDA: NDA Accepted for Review; PDUFA Date Set for June 25, 2012

QRxPharma Limited (ASX: QRX and OTCQX: QRXPY) announced today it received written acceptance from the United States Food and Drug Administration...


Aug 25, 2011, 08:05 ET QRxPharma Completes NDA Submission for MoxDuo® IR

QRxPharma Limited (ASX: QRX and OTCQX: QRXPY) announced today submission of its New Drug Application (NDA) clinical data package to the United States ...


Jul 25, 2011, 10:43 ET QRxPharma Announces A$35 Million Capital Raising to Progress MoxDuo Formulations and Support Commercialisation of MoxDuo® IR

QRxPharma Limited (ASX: QRX and OTCQX: QRXPY) is pleased to announce the successful completion of a placement to institutions and professional...


Jul 18, 2011, 04:45 ET QRxPharma Announces NDA Filing for MoxDuo® IR

QRxPharma Limited (ASX: QRX and OTCQX: QRXPY) announced today initiation of the New Drug Application (NDA) approval process for MoxDuo IR with the...